Table 4.
Adjusted odds ratio (AOR) of opioid overdose, emergency department (ED) admission, and inpatient hospitalization in relation to having chronic non-cancer pain (CNCP) vs. not having CNCP: stratified by substance use disorder diagnosis and by gender.
Patients with substance use disorder | Overall | Males | Females |
---|---|---|---|
AOR (95% CI) of opioid overdose | |||
Tobacco | 1.50 (1.25–1.81) | 1.42 (1.13–1.80) | 1.62 (1.18–2.22) |
Alcohol | 1.47 (1.10–1.96) | 1.23 (0.89–1.70) | 2.48 (1.30–4.73) |
Opioid | 0.49 (0.39–0.63) | 0.42 (0.31–0.56) | 0.70 (0.46–1.07) |
Other druga | 1.32 (1.06–1.63) | 1.08 (0.83–1.40) | 1.94 (1.29–2.90) |
AOR (95% CI) of ED admission | |||
Tobacco | 2.07 (1.99–2.14) | 1.95 (1.85–2.04) | 2.22 (2.11–2.35) |
Alcohol | 1.73 (1.60–1.87) | 1.80 (1.64–1.97) | 1.57 (1.36–1.81) |
Opioids | 1.09 (0.94–1.28) | 1.10 (0.89–1.36) | 1.10 (0.88–1.39) |
Other druga | 2.29 (2.08–2.53) | 2.03 (1.78–2.31) | 2.71 (2.33–3.16) |
AOR (95% CI) of inpatient hospitalization | |||
Tobacco | 1.28 (1.23–1.32) | 1.26 (1.20–1.32) | 1.31 (1.24–1.38) |
Alcohol | 1.26 (1.17–1.36) | 1.28 (1.17–1.39) | 1.22 (1.06–1.39) |
Opioids | 1.05 (0.91–1.22) | 1.30 (1.06–1.59) | 0.81 (0.65–1.02) |
Other druga | 1.21 (1.11–1.31) | 1.28 (1.15–1.42) | 1.14 (1.00–1.29) |
Note: Separate models were conducted among patients with tobacco, alcohol, opioid, or other (non-opioid) drug use disorder, respectively, and for each dependent variable including opioid overdose, ED admission, and inpatient hospitalization, respectively. The overall model was controlled for gender, age group, race/ethnicity, any mental health disorder, chronic medical condition, and any cancer diagnosis. Each gender-specific model was controlled for age group, race/ethnicity, any mental health disorder, and any chronic medical condition. CI: confidence interval; CNCP: chronic non-cancer pain; AOR: adjusted logistic regression; ED: emergency department.
Other (non-opioid) drug use disorders included cannabis, cocaine/amphetamine, sedative/hypnotic/anxiolytic, hallucinogen, inhalant, or other/unspecified drug use disorder.
Boldface: estimate significantly differed from the estimate without CNCP (p<0.05)